Literature DB >> 10939581

A de novo mutation in sporadic nocturnal frontal lobe epilepsy.

H A Phillips1, C Marini, I E Scheffer, G R Sutherland, J C Mulley, S F Berkovic.   

Abstract

Autosomal dominant nocturnal frontal lobe epilepsy is sometimes due to mutations in CHRNA4. The commoner presentation of sporadic nocturnal frontal lobe epilepsy has not been associated with genetic defects. A 30-year-old woman diagnosed as having sporadic nocturnal frontal lobe epilepsy was found to have a de novo Ser252Leu CHRNA4 mutation. A pattern is emerging of site-specific mutation within the second transmembrane domain of CHRNA4 in association with autosomal dominant nocturnal frontal lobe epilepsy and sporadic nocturnal frontal lobe epilepsy in families with different ethnic backgrounds.

Entities:  

Mesh:

Year:  2000        PMID: 10939581

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

Review 1.  Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview.

Authors:  Romina Combi; Leda Dalprà; Maria Luisa Tenchini; Luigi Ferini-Strambi
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

2.  Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Zhihong Chen; Lingan Wang; Chun Wang; Qian Chen; Qiongxiang Zhai; Yuxiong Guo; Yuxin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 3.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

4.  Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy.

Authors:  David N Bowser; David A Wagner; Cynthia Czajkowski; Brett A Cromer; Michael W Parker; Robyn H Wallace; Louise A Harkin; John C Mulley; Carla Marini; Samuel F Berkovic; David A Williams; Mathew V Jones; Steven Petrou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

5.  CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  H A Phillips; I Favre; M Kirkpatrick; S M Zuberi; D Goudie; S E Heron; I E Scheffer; G R Sutherland; S F Berkovic; D Bertrand; J C Mulley
Journal:  Am J Hum Genet       Date:  2000-12-05       Impact factor: 11.025

Review 6.  Neurodevelopmental liabilities in epilepsy.

Authors:  Antonio Gil-Nagel
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 7.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

8.  Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Authors:  Geeta Sharma; Sukumar Vijayaraghavan
Journal:  Subst Abuse       Date:  2008-11-11

Review 9.  Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain.

Authors:  Danielle M Andrade
Journal:  Hum Genet       Date:  2009-06-18       Impact factor: 4.132

10.  A targeted resequencing gene panel for focal epilepsy.

Authors:  Michael S Hildebrand; Candace T Myers; Gemma L Carvill; Brigid M Regan; John A Damiano; Saul A Mullen; Mark R Newton; Umesh Nair; Elena V Gazina; Carol J Milligan; Christopher A Reid; Steven Petrou; Ingrid E Scheffer; Samuel F Berkovic; Heather C Mefford
Journal:  Neurology       Date:  2016-03-30       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.